Vivos Therapeutics announces $3.5M registered direct offering of 709,220 shares and warrants

Vivos Therapeutics, Inc.

Gross proceeds of ~$3.5M from 709,220 shares at $4.935 each; warrants exercisable at $4.81 for two years.
Additional ~$3.4M if warrants fully exercised; net proceeds for working capital and general corporate purposes.
H.C. Wainwright receives 7% cash fee, 1% management fee, and placement agent warrants for 49,645 shares at $6.1688.
Closing expected Dec 24, 2024; 45-day lock-up on share issuance and one-year restriction on variable rate transactions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.